Silvercrest Asset Management Group LLC Mirum Pharmaceuticals, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q4 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 136,700 shares of MIRM stock, worth $6.54 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
136,700
Previous 138,047
0.98%
Holding current value
$6.54 Million
Previous $5.38 Million
5.0%
% of portfolio
0.04%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$315 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$219 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$155 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$134 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$125 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.76B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...